VIR News and Press, Vir Biotechnology Inc. From 10/04/22

– First award from the agency’s solicitation for contracts for Pre-Exposure Prophylaxis for Influenza – – Initial investment of approximately $55 million from Biomedical Advanced Research and Development Authority to support development of V...

Vir Biotechnology ( NASDAQ: VIR ) said the first patient was dosed in a phase 2 trial of VIR-2218 and VIR-3434 as monotherapy and in combination to treat people with chronic hepatitis D virus (HDV), which occurs as a simultaneous co-infection  or super-infec...

– Impacting more than 12 million people globally, HDV is the most aggressive form of viral hepatitis – – Novel combination strategy designed to reduce HDV viremia and block viral entry – SAN FRANCISCO, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Vi...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks have performed relatively well compared to the broader market of late. The SPDR S&P Biotech ETF (NYSEARCA: XBI ) is up 21% over the past three months compared with a 6% gain for the S&P 500 . ...

Summary Pharmaceuticals/biotechnology and healthcare providers are undervalued relative to 11-year averages. Healthcare equipment is the most overpriced subsector. Fast facts on IYH, an alternative to XLV. 10 stock cheaper than their peers in September. This mont...

SAN FRANCISCO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company will participate in a fireside chat at the Morgan Stanley 20 th Annual Global Healthcare Conference on Tuesday, September 13, at 4:05 p.m. ET. A live webcast of...

The Director of the Centers for Disease Control and Prevention (CDC), Rochelle Walensky, announced plans to overhaul the agency on Wednesday after multiple errors in the COVID response battered its reputation. In an email sent to CDC staff, Dr. Walensky said reforms would include re...

As the U.S. prepares to transition from the acute phase of the pandemic, the Biden administration will stop purchases of COVID-19 vaccines, treatments, and tests as early as this fall, the White House COVID response coordinator Ashish Jha said. "My hope is that in 2023, you're going...

Pharmaceutical/biotechnology is the subsector with the highest value and quality scores. Life science tools and healthcare equipment are the most overvalued. Fast facts on IDNA. 10 stocks cheaper than their peers in August. This monthly article series shows a dashboa...

The Centers for Disease Control and Prevention (CDC) on Thursday revised recommendations for unvaccinated people easing the guidance on isolation following exposure to the virus. Per the latest advice, the CDC no longer recommends unvaccinated people to quarantine after exposure, ...